Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

被引：0

作者：

O Nehls

B Klump

H T Arkenau

H G Hass

A Greschniok

M Gregor

R Porschen

机构：

[1] University Hospital,Department of Internal Medicine I

[2] University Hospital,Department of Pathology

[3] Clinic of Internal Medicine,undefined

[4] Central Hospital Bremen Ost,undefined

来源：

British Journal of Cancer | 2002年 / 87卷

关键词：

biliary carcinoma; chemotherapy; 5-fluorouracil; oxaliplatin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We studied the activity of combined oxaliplatin and fluorouracil-leucovorin in 16 consecutive patients with advanced biliary tract adenocarcinomas. The disease control rate (responses and stable disease) was 56% (95% confidence interval, 29–84%) and the median overall survival time was 9.5 months (range 0.9–26.8+). Therefore, this regimen might be active in biliary adenocarcinomas with further evaluation necessary.

引用

页码：702 / 704

页数：2

共 50 条

[21] Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer
Rabih Said
Yang Ye
David S. Hong
Aung Naing
Gerald Falchook
Siqing Fu
Jennifer J. Wheler
Sarina Piha-Paul
Apostolia-Maria Tsimberidou
Cancer Chemotherapy and Pharmacology, 2016, 77 : 575 - 581
[22] Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial
O Nehls
H Oettle
J T Hartmann
R-D Hofheinz
H G Hass
M S Horger
U Koppenhöfer
A Hochhaus
J Stieler
J Trojan
M Gregor
B Klump
British Journal of Cancer, 2008, 98 : 309 - 315
[23] Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma:: a prospective multicentre phase II trial
Nehls, O.
Oettle, H.
Hartmann, J. T.
Hofheinz, R-D
Hass, H. G.
Horger, M. S.
Koppenhoefer, U.
Hochhaus, A.
Stieler, J.
Trojan, J.
Gregor, M.
Klump, B.
BRITISH JOURNAL OF CANCER, 2008, 98 (02) : 309 - 315
[24] Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer
Vanna Chiarion-Sileni
Roberto Innocente
Raffaele Cavina
Alberto Ruol
Luigi Corti
Jacopo Pigozzo
Paola Del Bianco
Uberto Fumagalli
Armando Santoro
Ermanno Ancona
Cancer Chemotherapy and Pharmacology, 2009, 63
[25] Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer
Chiarion-Sileni, Vanna
Innocente, Roberto
Cavina, Raffaele
Ruol, Alberto
Corti, Luigi
Pigozzo, Jacopo
Del Bianco, Paola
Fumagalli, Uberto
Santoro, Armando
Ancona, Ermanno
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1111 - 1119
[26] A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma
Sanz-Altamira, PM
Ferrante, K
Jenkins, RL
Lewis, WD
Huberman, MS
Stuart, KE
CANCER, 1998, 82 (12) : 2321 - 2325
[27] Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma
Andre, T
Lotz, JP
Bouleuc, C
Azzouzi, K
Houry, S
Hannoun, L
See, J
Esteso, A
Avenin, D
Izrael, V
ANNALS OF ONCOLOGY, 1996, 7 (02) : 173 - 178
[28] Preliminary phase II results of oxaliplatin, 5-FU, and leucovorin in advanced biliary tract cancer.
Lee, S.
Kim, H.
Kim, S.
Kim, C.
Bae, S.
Lee, K.
Yun, J.
Hong, D.
Park, H.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[29] Oxaliplatin with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced colorectal cancer patients: A phase II study
Yang, TS
Chen, JS
Tang, RP
Chiang, JM
Hsieh, PS
Yeh, CY
Changchien, CR
CHEMOTHERAPY, 2003, 49 (04) : 194 - 199
[30] Oxaliplatin/fluorouracil/leucovorin in advanced colorectal carcinoma: an Asian experience
Lim, EH
Lim, RSC
Wu, TS
Kong, HL
ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) : 1909 - 1912

← 1 2 3 4 5 →